Airsculpt Technologies Accounts Payable Over Time
| AIRS Stock | USD 5.35 0.14 2.55% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Airsculpt Technologies Performance and Airsculpt Technologies Correlation. Airsculpt |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Airsculpt Technologies. If investors know Airsculpt will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Airsculpt Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2 | Earnings Share (0.14) | Revenue Per Share 3.287 | Quarterly Revenue Growth (0.09) | Return On Assets 0.0112 |
The market value of Airsculpt Technologies is measured differently than its book value, which is the value of Airsculpt that is recorded on the company's balance sheet. Investors also form their own opinion of Airsculpt Technologies' value that differs from its market value or its book value, called intrinsic value, which is Airsculpt Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Airsculpt Technologies' market value can be influenced by many factors that don't directly affect Airsculpt Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Airsculpt Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Airsculpt Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Airsculpt Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Accounts Payable Analysis
Compare Airsculpt Technologies and related stocks such as Acadia Healthcare, Pennant Group, and Aesthetic Medical Intl Accounts Payable Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACHC | 833 K | 8.6 M | 19.1 M | 36 M | 48.7 M | 91.3 M | 80 M | 102.3 M | 117.7 M | 127 M | 87.8 M | 98.6 M | 104.7 M | 156.1 M | 84.8 M |
| PNTG | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 4.4 M | 8.7 M | 9.8 M | 10.6 M | 13.6 M | 10.8 M | 9.6 M |
| AMED | 300 K | 25.5 M | 29.2 M | 20.1 M | 16.1 M | 25.7 M | 30.4 M | 25.4 M | 28.5 M | 31.3 M | 42.7 M | 38.2 M | 43.7 M | 28.2 M | 19 M |
| ENSG | 11 M | 21.2 M | 26.1 M | 23.8 M | 33.2 M | 36 M | 39 M | 39 M | 44.2 M | 45 M | 50.9 M | 58.1 M | 77.1 M | 92.8 M | 97.5 M |
| UHS | 29 M | 228 M | 247 M | 276.9 M | 1.1 B | 1 B | 1.2 B | 1.3 B | 1.4 B | 1.3 B | 570.5 M | 658.9 M | 636.6 M | 614 M | 426.3 M |
| ADUS | 2.6 M | 5.3 M | 4.1 M | 4.6 M | 4 M | 4.7 M | 4.5 M | 4.3 M | 12.2 M | 86.8 M | 23.7 M | 19.4 M | 22.1 M | 26.2 M | 15.2 M |
| EHC | 13.3 M | 45.4 M | 45.3 M | 61.9 M | 53.4 M | 61.6 M | 68.3 M | 78.4 M | 90 M | 94.6 M | 115 M | 134 M | 132.9 M | 170 M | 178.5 M |
| SGRY | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 43.1 M | 45.3 M | 49.8 M | 84.7 M | 83.3 M | 96.7 M | 100.2 M | 124.9 M | 151.6 M | 171.8 M | 97 M |
| SEM | 60.5 M | 95.6 M | 89.5 M | 88.3 M | 108.5 M | 137.4 M | 126.6 M | 128.2 M | 146.7 M | 145.7 M | 177.1 M | 233.8 M | 186.7 M | 174.3 M | 131.2 M |
| INNV | 362.2 K | 362.2 K | 362.2 K | 362.2 K | 362.2 K | 63.8 K | 647.1 K | 2.3 M | 30.4 M | 28.9 M | 32.4 M | 50.6 M | 44.6 M | 55.5 M | 58.2 M |
| EHAB | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 3.5 M | 3.8 M | 7.6 M | 5 M |
| CCEL | 100 K | 1.2 M | 1.2 M | 992.9 K | 1.3 M | 1.5 M | 1.9 M | 1.3 M | 1.4 M | 957.4 K | 1.5 M | 1.6 M | 3.2 M | 3.7 M | 3.8 M |
| AVAH | 38 M | 38 M | 38 M | 38 M | 38 M | 38 M | 38 M | 38 M | 38 M | 66.4 M | 19.6 M | 52.6 M | 44.6 M | 30.1 M | 33.5 M |
| TOI | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 12.6 M | 15.6 M | 9.4 M | 14.4 M | 13.4 M |
Airsculpt Technologies and related stocks such as Acadia Healthcare, Pennant Group, and Aesthetic Medical Intl Accounts Payable description
An accounting item on the balance sheet that represents Airsculpt Technologies obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Airsculpt Technologies are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.My Equities
My Current Equities and Potential Positions
| Airsculpt Technologies | AIRS |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Florida; U.S.A |
| Exchange | NASDAQ Exchange |
USD 5.35
Additional Tools for Airsculpt Stock Analysis
When running Airsculpt Technologies' price analysis, check to measure Airsculpt Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Airsculpt Technologies is operating at the current time. Most of Airsculpt Technologies' value examination focuses on studying past and present price action to predict the probability of Airsculpt Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Airsculpt Technologies' price. Additionally, you may evaluate how the addition of Airsculpt Technologies to your portfolios can decrease your overall portfolio volatility.